Background of the study: Pediatric bronchial asthma is a common chronic airway disorder which requires long term management. Globally, irrational prescribing poses a huge problem which increases the cost of treatment as well as incidence of adverse drug reactions. This emphasizes dire necessity for monitoring of prescriptions pattern. As such, this study was planned. Materials and Methods: An observational, non–interventional, and cross–sectional study was conducted in a tertiary care teaching hospital in Aurangabad. All childhood asthma patients attending outpatient department were enrolled in the study in accordance with inclusion and exclusion criteria. Patient’s demographic details, details of anti–asthmatic drugs, and all other drugs such as dose, duration, type of dosage form used, frequency of drug administration, etc. were recorded. Results: Out of 300 children enrolled in the study, majority were males and belonged to the age group of 6–10 years. 43.67% patients received single anti–asthmatic drug whereas, 56.34% patients received multiple drug therapy. Average number of drugs per prescription was 2.89. Inhalational route was preferred and all the drugs were prescribed by their brand names. Short acting beta 2 agonists (85%) was prescribed the most followed by (47.66%) inhalational corticosteroids. Antibiotics were prescribed in 11.33% patients. Conclusion: Prescribing trends in anti–asthmatic drugs were mainly in accordance with the standard treatment guidelines. However, all the drugs were prescribed by brand names. To overcome this, training should be provided to health care practitioners regarding WHO drug policies and significance of generic prescribing.